Sof marja: uniQure (QURE)

uniQure N.V. (QURE) tovar belgisi

uniQure N.V. (QURE) rahbariyati kapital xarajatlarini nazorat qilgan holda sinovlarning shaffofligini ta'minlamoqda. Joriyligi hamkorlik shartnomalari va istiqbolli mahsulotlarning ishga tushirilishiga bog'liq. GURU.Markets terminali grafigidagi nisbiy sof savdo foydasi daromadlilikni namoyish etadi, bunda -1154.80 ushbu ko'rsatkichning joriy hajmini ko'rsatadi. Gemofiliya davolashiga bo'lgan talab doimiy qolayotgani sababli, ushbu biznes iqtisodiy sikllardan mustaqildir.

QURE: uniQure N.V. Sotuvning sof marjinal rentabelligi 04.07.2022 - 20.11.2026

uniQure N.V. kompaniyasining tahliliy kesimlari

- aksiya narxi va baholash bo'yicha konsensus prognoz:
- kompaniyaning birjadagi kapitallashuv ko'rsatkichlari:
Kompaniyaning jamlanma tahlili:uniQure N.V.
uniQure NV yetakchi tovari

Barqarorlik omillarini aniqlash uchun investorlar sof foyda marjasi orqali mahsulot sotuvlaridan tushgan daromadning haqiqiy foizini aks ettiruvchi sof foyda va tushum nisbatini kuzatishlari kerak. uniQure N.V. (QURE) uchun ushbu tendentsiya dori vositalarining keng ko'lamli klinik sinovlarini amalga oshiruvchi tashqi CRO tarmoqlari bilan bog'liq xarajatlarni boshqarish samaradorligiga bevosita bog'liq.

Muhim raqobatchilar

TEM: Sotuvning sof marjinal rentabelligi|Sof foyda bo'yicha marjinallik Qiagen QGEN|IONS (Isis Pharmaceuticals) - Sotuvning sof marjinal rentabelligi|Repligen Inc. - Sof foyda marjasi|Sotuvning sof marjinal rentabelligi RNA|CRSP - Sof marja|GeneDx - Sof foyda bo'yicha sotuv rentabelligi|Sof foyda normasi RARE|Beam Tx - Sotuvning sof marjinal rentabelligi|SRPT - Sotuvning sof marjinal rentabelligi|TWST (Twist Bio) - Sof foyda bo'yicha sotuv rentabelligi|Sotuvning sof rentabelligi TXG|Sof foyda bo'yicha sotuv rentabelligi NTLA|Stoke Therapeutics Inc (STOK) - Kompaniya sotuv marjasi|Sotuvning sof marjinal rentabelligi BLFS|Sof marja WVE (Wave Life Sciences Corp)|Sof marja Maze Therapeutics MAZE|Sof foyda normasi SION|PRME - Sof marja|Kompaniya sotuv marjasi Taysha TSHA|MeiraGTx Corp (MGTX) - Sof marja|Regenxbio - Sof foyda normasi|Sof marja solidbio.com|Sof marja ocugen.com OCGN|Sotuvning sof marjinal rentabelligi PACB|Benitec - Sotuvning sof rentabelligi|Sof marja Design Therapeutics DSGN|Sotuvning sof marjinal rentabelligi Rocket Pharmaceuticals RCKT|Sof foyda marjasi 4D Molecular Corp|LXEO: Sof marja|KRRO (Korro Bio, Inc) - Sof foyda bo'yicha sotuv rentabelligi|Editas Medicine (EDIT) - Sotuvning sof marjinal rentabelligi|Sof marja Silence Therapeutics Inc.|Sotuvning sof rentabelligi PRQR (proqr.com)|Sof marja Codexis Bio (CDXS)|Sotuvning sof marjinal rentabelligi sangamo.com (SGMO)|Sof marja nautilus.bio NAUT|Kompaniya sotuv marjasi Metagenomi, Inc (MGX)|Precision BioSciences Inc. - Sotuvning sof marjinal rentabelligi|GBIO - Sotuvning sof marjinal rentabelligi|BOLD: Sotuvning sof marjinal rentabelligi|Sotuvning sof rentabelligi XCUR|Sof marja Imunon|Phio Pharmaceuticals - Sof foyda marjasi|Sof marja Mustang Bio, Inc. (MBIO)|Kompaniya sotuv marjasi TransCode Therapeutics, Inc.|Sof marja Bionano Genomics BNGO|Sof foyda normasi APDN|BLUE - Sof marja|Sof foyda marjasi IPA|Omega Therapeutics, Inc. (OMGA) - Sof marja|Singular Genomics Corp (OMIC) - Sotuvning sof marjinal rentabelligi|RGLS (Regulus Therapeutics, Inc.) - Sotuvning sof marjinal rentabelligi|SYRS: Sof foyda normasi|Sof foyda bo'yicha sotuv rentabelligi TBIO (Telesis Bio Inc.)|Sotuvning sof marjinal rentabelligi TRACON Pharmaceuticals Inc. (TCON)|Sof marja Unity Bio UBX